Speaker 1: Barbara Sahakian, UK

نویسندگان

  • Kang-Seob Oh
  • Barbara Sahakian
  • UK
چکیده

s | 23 forced swimming test, and antidepressant effects were attenuated by local injection of NBQX into the mPFC, indicating that both an mGlu2/3 receptor antagonist and ketamine exert the effects through AMPA receptor stimulation in the mPFC. In addition, we found that depletion of serotonin blocked antidepressant effects induced by local injection of LY341495 or ketamine into the mPFC. We also found that both compounds increased the c-Fos expression in the serotonin neurons in the dorsal raphe nucleus (DRN), which was blocked by local injection of NBQX into the mPFC, suggesting that both compounds may activate subsets of serotonin neurons in the DRN regulated by AMPA receptor stimulation in the mPFC. These studies revealed that mGlu2/3 receptor antagonists exhibited similar antidepressant profiles with ketamine in animal models in that they exerted rapid and sustained effects and were effective in animal models refractory to current medications. Moreover, mGlu2/3 receptor antagonists may share mechanisms underlying antidepressant effects with ketamine at both synaptic and neural levels. Therefore, mGlu2/3 receptor antagonists may be useful as an alternative approach to treating patients with TRD. Other agents including GLYX-13 and GluN2B antagonists which could be alternatives to ketamine will also be briefly discussed. CP02: Anxiety Title: Clinical perspective of Anxiety Disorders in Korea Speaker 1: Dan Stein, South Africa Speaker 2: Kang-Seob Oh, Republic of Korea Abstract Since 21st century, anxiety disorders(Generalized Anxiety disorder, Panic Disorder, Social Anxiety disorder) are no more ignorant in Korea. Many studies including epidemiologic, clinical characteristic, and treatment studies of anxiety disorders were published in Korea. In this session, the speaker will present about prevalence rate of anxiety disorders, clinical characteristics of anxiety disorders, and treatment results studies of anxiety disorders in Korea. The speaker will also introduce some treatment guidelines of anxiety disorders in Korea.Since 21st century, anxiety disorders(Generalized Anxiety disorder, Panic Disorder, Social Anxiety disorder) are no more ignorant in Korea. Many studies including epidemiologic, clinical characteristic, and treatment studies of anxiety disorders were published in Korea. In this session, the speaker will present about prevalence rate of anxiety disorders, clinical characteristics of anxiety disorders, and treatment results studies of anxiety disorders in Korea. The speaker will also introduce some treatment guidelines of anxiety disorders in Korea.

برای دانلود رایگان متن کامل این مقاله و بیش از 32 میلیون مقاله دیگر ابتدا ثبت نام کنید

ثبت نام

اگر عضو سایت هستید لطفا وارد حساب کاربری خود شوید

منابع مشابه

Op-brai140118 1986..1997

1 Department of Neuroimaging, Institute of Psychiatry, King’s College London, London SE5 8AF, UK 2 Behavioural and Clinical Neuroscience Institute, University of Cambridge, Cambridge, UK 3 Cambridge Cognition Limited, Cambridge, UK 4 Department of Psychiatry, University of Cambridge, Cambridge, UK 5 Division of Clinical Pharmacology, Rudolf-Boehm-Institute of Pharmacology and Toxicology, Univer...

متن کامل

Title: Clinical perspective of Anxiety Disorders in Korea

s | 23 forced swimming test, and antidepressant effects were attenuated by local injection of NBQX into the mPFC, indicating that both an mGlu2/3 receptor antagonist and ketamine exert the effects through AMPA receptor stimulation in the mPFC. In addition, we found that depletion of serotonin blocked antidepressant effects induced by local injection of LY341495 or ketamine into the mPFC. We als...

متن کامل

CNS Spectrums

How to cite this article: Naomi A Fineberg, Samuel R. Chamberlain, Anna E. Goudriaan, Dan J. Stein, Louk J. M. J. Vanderschuren, Claire M. Gillan, Sameer Shekar, Philip A. P. M. Gorwood, Valerie Voon, Sharon Morein-Zamir, Damiaan Denys, Barbara J. Sahakian, F. Gerard Moeller, Trevor W. Robbins and Marc N. Potenza (2014). New developments in human neurocognition: clinical, genetic, and brain ima...

متن کامل

Speaker: Naomi Fineberg, UK

s | 47 PL06 Obsessive Compulsive Disorder Chair: Brian Dean, Australia Speaker: Naomi Fineberg, UK Title: Mapping Compulsivity: Cognitive Domains, Neural Circuitry And Treatment Fineberg Naomi A 1,2,3, Apergis-Schoute Annemieke M4, Vaghi Mathilde 4,5, Banca Paula 4,5, Chamberlain Samuel R3,4,6, Cinosi Eduardo2,7, Reid Jemma1,2, Bullmore Edward T3, Sahakian Barbara J3,4, Robbins Trevor W4,5. 1H...

متن کامل

Proceedings of the 2013 CINP Summit: Innovative Partnerships to Accelerate CNS Drug Discovery for Improved Patient Care

Central nervous system (CNS) diseases and, in particular, mental health disorders, are becoming recognized as the health challenge of the 21(st) century. Currently, at least 10% of the global population is affected by a mental health disorder, a figure that is set to increase year on year. Meanwhile, the rate of development of new CNS drugs has not increased for many years, despite unprecedente...

متن کامل

ذخیره در منابع من


  با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید

عنوان ژورنال:

دوره 19  شماره 

صفحات  -

تاریخ انتشار 2016